In vitro metabolic fate of a novel structural class: evidence for the formation of a reactive intermediate on a benzothiophene moiety.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Chemico-Biological Interactions

• Publication date

  2005-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CBI.2005.01.005PMID 15766920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity.

  2004cited by this paper
• The use of radiolabeled compounds for ADME studies in discovery and exploratory development.

  2004cited by this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cited by this paper
• Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques.

  2003cited by this paper
• Screening for the potential of a drug candidate to cause idiosyncratic drug reactions.

  2003cited by this paper
• Detoxication pathways involving glutathione and epoxide hydrolase in the in vitro metabolism of chloroprene.

  2003cited by this paper
• Reactive intermediates and the dynamics of glutathione transferases.

  2002cited by this paper
• In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist.

  2002cited by this paper
• Biotransformation reactions of five-membered aromatic heterocyclic rings.

  2002cited by this paper
• Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation.

  2002cited by this paper
• Systematic LC/MS metabolite identification in drug discovery.

  2001cited by this paper
• Glutathione depletion in rat hepatocytes: a mixture toxicity study with α,β-unsaturated esters

  2001cited by this paper
• Glutathione depletion in rat hepatocytes: a mixture toxicity study with alpha, beta-unsaturated esters.

  2001cited by this paper
• Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

  2001cited by this paper
• Idiosyncratic drug reactions: the reactive metabolite syndromes.

  2000cited by this paper
• Metabolism of lamotrigine to a reactive arene oxide intermediate.

  2000cited by this paper
• Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds.

  1999cited by this paper
• Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.

  1999cited by this paper
• Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.

  1999cited by this paper
• Synthesis of (4-chlorophenyl)-(1-oxo-1λ4-benzo[b]thien-2-yl)methanone and study of its reactivity towards sulfur- and oxygen-containing nucleophiles

  1998cited by this paper
• Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.

  1997cited by this paper
• Molecular structure and hepatotoxicity: compared data about two closely related thiophene compounds.

  1997cited by this paper
• Chemical and Biological Oxidation of Thiophene: Preparation and Complete Characterization of Thiophene S-Oxide Dimers and Evidence for Thiophene S-Oxide as an Intermediate in Thiophene Metabolism in Vivo and in Vitro

  1997cited by this paper
• Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).

  1996cited by this paper
• Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo.

  1996cited by this paper
• Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.

  1995cited by this paper
• Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.

  1994cited by this paper
• Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes.

  1993cited by this paper
• An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.

  1992cited by this paper
• Thiophene S‐Oxides as New Reactive Metabolites: Formation by Cytochrome P450 Dependent Oxidation and Reaction with Nucleophiles.

  1992cited by this paper
• Evidence for thiophene-S-oxide as a primary reactive metabolite of thiophene in vivo: formation of a dihydrothiophene sulfoxide mercapturic acid.

  1992cited by this paper
• Thiophene S-oxides as new reactive metabolites: formation by cytochrome P-450 dependent oxidation and reaction with nucleophiles

  1991cited by this paper
• Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis.

  1988cited by this paper
• The enzymatic conjugation of glutathione with bay-region diol-epoxides of benzo[a]pyrene, benz[a]anthracene and chrysene.

  1986cited by this paper
• Pathways involved in the metabolism and activation of polycyclic hydrocarbons.

  1986cited by this paper
• Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds

  1972cited by this paper

• Optimizing Pharmacokinetic Properties and Attaining Candidate Selection

  2012cites this paper
• Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione.

  2009cites this paper
• Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.

  2009cites this paper
• Analytical Tools and Approaches for Metabolite Identification in Early Drug Discovery

  2007cites this paper
• HPLC with Column Switching Coupled to APCI–MS for Pharmacokinetic Study of Amygdalin in Rabbit Plasma

  2007cites this paper
• Drug withdrawals and the lessons within.

  2006cites this paper
• Structure–Activity Relationships for In vitro and In vivo Toxicity

  2006cites this paper